Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi Yuki, MD, Takeshi Mimura, MD, Kei Miyoshi, MD, Noriaki Tsubota, MD, PhD The Annals of Thoracic Surgery Volume 81, Issue 3, Pages 1028-1032 (March 2006) DOI: 10.1016/j.athoracsur.2005.09.078 Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Disease-free (A) and overall (B) survival curves of all patients with clinical and surgical stage I disease, stratified by the type of mediastinal dissection. The Annals of Thoracic Surgery 2006 81, 1028-1032DOI: (10.1016/j.athoracsur.2005.09.078) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Disease-free (A) and overall (B) survival curves of patients with clinical and surgical stage I disease except those with bronchioloalveolar carcinoma, stratified by the type of mediastinal dissection. The Annals of Thoracic Surgery 2006 81, 1028-1032DOI: (10.1016/j.athoracsur.2005.09.078) Copyright © 2006 The Society of Thoracic Surgeons Terms and Conditions